Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2011-05-25
Original SEC Filing: Click here

---

Webplus: BSPM/20110525/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Chairman and CEO of Biostar Pharmaceuticals,opts 10b5-1 Share Repurchase Plan Rule 10b5-1 permitsrporate officers, directors and others toopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. These planslow insiders to have shares bought or sold for their accounts over a period of time regardless of any material, non-public

---

---

Webplus: BSPM/20110525/8-K/1/000.htm SEC Original: biostarpharma8k052511.htm
______________ FORM 8-K ______________ CURRENT REPORTte of Report (Date of earliest event reported):May 25, 2011 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2011-05-25CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046